Glossary

AJAX progress indicator
Search:
(clear)
  • Surrogate endpoint
    The endpoint in a clinical trial is an event such as the occurrence of a disease, or symptom, or a particular laboratory result. Once someone reaches the endpoint, they are generally excluded from further research in the trial.A surrogate endpoint (or marker) is a measure which in itself is(...)
  • SUSAR
    A Suspected Unexpected Serious Adverse Reaction (SUSAR), is a serious adverse reaction (SAR) for which a reasonable causal relationship with the medicine use is suspected but not confirmed. Unexpected in this context means not consistent with the applicable product information (e.g.(...)
  • Suspected Unexpected Serious Adverse Reaction
    A Suspected Unexpected Serious Adverse Reaction (SUSAR), is a serious adverse reaction (SAR) for which a reasonable causal relationship with the medicine use is suspected but not confirmed. Unexpected in this context means not consistent with the applicable product information (e.g.(...)
  • Swiss Agency for Therapeutic Products
    Swiss National Competent Authority. https://www.swissmedic.ch"
  • Swissmedic
    Swiss National Competent Authority. https://www.swissmedic.ch"
  • Systemic toxicology
    This refers to toxic effects caused as a result of absorption and distribution of a substance that affects the whole body rather than a specific (local) area, i.e. to an area distant from its entry point. Most chemicals that produce systemic toxicity do not cause a similar degree of toxicity(...)
  • Target patient population
    Refers to the patients the medicine is intended for.
  • Target Product Profile
    A target product profile is a document that describes the features of a product (such as a medicine) that a company is planning or developing. The document can include a wide range of information such as dosage, how the product will be administered (for example this could be a patient taking a(...)
  • Targeted medicine
    These are medicines designed in a manner that focuses the activity of the medication in certain parts of the body. The goal of a targeted medicine is to increase the length of time that the medicine interacts with the diseased tissue in a specific area of the body and spares other parts (e.g.(...)
  • Terveyden ja hyvinvoinnin laitos
    Finnish National Institute for Health and Welfare. https://www.thl.fi"
  • Therapeutic Alternatives
    Therapeutic alternatives are medicines that are chemically different from the one prescribed (used) but which have the same clinical effect. Therapeutic alternatives are not to be confused with generics.
  • Therapeutic indication
    Therapeutic indications are a description of the disease to be treated with a medicine, and the population for which the medicine is intended. They include the specifics about the disease, and restrictions to the patient population such as age, and whether the medicine is intended for symptom(...)
  • THL
    Finnish National Institute for Health and Welfare. https://www.thl.fi"
  • TPP
    A target product profile is a document that describes the features of a product (such as a medicine) that a company is planning or developing. The document can include a wide range of information such as dosage, how the product will be administered (for example this could be a patient taking a(...)

Find Out More